Breaking News Instant updates and real-time market news.

OCN

Ocwen

$2.53

0.0401 (1.61%)

14:47
04/21/17
04/21
14:47
04/21/17
14:47

Oppenheimer says a time will come to buy Ocwen, just not today

  • 03

    May

  • 24

    May

OCN Ocwen
$2.53

0.0401 (1.61%)

04/20/17
KBWI
04/20/17
NO CHANGE
Target $5
KBWI
Market Perform
Immediate Ocwen impact from orders, lawsuit should be small, says Keefe Bruyette
Keefe Bruyette analyst Bose George noted that Ocwen is not currently purchasing servicing, so he believes the immediate impact from states issuing Cease-and-Desist orders and from the CFPB lawsuit against the company should be small. However, expenses could stay elevated and growth may be limited, even if it the company settles with NY DFS as expected, he added. George has a Market Perform rating and $5 price target on Ocwen shares, which are off their lows but remain down about 50% at $2.69.
04/21/17
COMP
04/21/17
UPGRADE
Target $3.5
COMP
Buy
Ocwen upgraded to Buy from Neutral at Compass Point
Compass Point analyst Frederick Small upgraded Ocwen (OCN) to Buy from Neutral as he sees regulatory risk as mispriced following yesterday's CFPB lawsuit and states' cease-and-desist orders. He also does not think New Residential (NRZ) will transfer the majority of Ocwen's subservicing to another servicer, though he lowered his price target on Ocwen shares to $3.50 from $5.
04/21/17
COWN
04/21/17
NO CHANGE
COWN
CFPB, states not looking to put Ocwen out of business, says Cowen
Cowen analyst Jaret Seiberg does not believe the CFPB and the states are looking to put Ocwen out of business despite the latest litigation over how the company services mortgages. He believes forcing the movement of mortgages servicing is fraught with risk for the borrowers as payments can get misplaced, data can be lost, and modification efforts could be derailed. Seiberg said the mortgage servicing business is complex and technical and proving any violations is a low hurdle to clear. He believes the company's fight with NY regulators put them in the crosshairs of other states and that Ocwen "will always attract additional attention." He also noted there are supposedly 1,000 customers that claim they wrongfully had foreclosure proceedings initiated because of Ocwen errors, but based on previous history, he doubts that will end up being the case. Ocwen is not covered by Cowen research and the firm does not have a rating on the stock.
04/21/17
SBSH
04/21/17
NO CHANGE
SBSH
Buy
New Residential has protections investors are overlooking, says Citi
Citi analyst Michael Kaye views the Ocwen's (OCN) CFPB lawsuit and state cease and desist orders as a clear negative development for New Residential Investment (NRZ), but the analyst yesterday afternoon kept a Buy rating on the shares. The analyst believes Ocwen services about $120B of New Residential's $600B servicing portfolio. Kaye, however, thinks New Residential has some flexibility since Ocwen's Moody's servicer rating is below SQ3, which qualifies as a potential legal termination event. As such, New Residential has the legal right to move the servicing into its own name and let Ocwen stay on as a sub-servicer, which would provide additional protection, Kaye told investors in a research note. The company can also pull the servicing agreement from Ocwen to another sub-servicer, he adds. Kaye believes New Residential "has some built in protections that investors might be overlooking."

TODAY'S FREE FLY STORIES

GE

General Electric

$29.55

-0.72 (-2.38%)

07:26
04/24/17
04/24
07:26
04/24/17
07:26
Periodicals
GE CFO Bornstein concerned over U.S. business confidence, FT reports »

General Electric CFO Jeff…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 09

    May

  • 22

    Jun

BCR

C.R. Bard

$253.07

-1.7 (-0.67%)

, BDX

Becton Dickinson

$185.29

-0.76 (-0.41%)

07:25
04/24/17
04/24
07:25
04/24/17
07:25
Recommendations
C.R. Bard, Becton Dickinson analyst commentary  »

C.R. Bard price target…

BCR

C.R. Bard

$253.07

-1.7 (-0.67%)

BDX

Becton Dickinson

$185.29

-0.76 (-0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 03

    May

  • 04

    May

  • 06

    Jun

07:25
04/24/17
04/24
07:25
04/24/17
07:25
General news
FX Update: The euro surged »

FX Update: The euro…

MTSI

MACOM

$51.74

-0.07 (-0.14%)

, SBGI

Sinclair Broadcast

$39.90

-0.45 (-1.12%)

07:24
04/24/17
04/24
07:24
04/24/17
07:24
Conference/Events
National Association of Broadcasters to hold a conference »

NAB Show 2017 is being…

MTSI

MACOM

$51.74

-0.07 (-0.14%)

SBGI

Sinclair Broadcast

$39.90

-0.45 (-1.12%)

NXST

Nexstar

$69.10

0.3 (0.44%)

TRCO

Tribune Media

$37.35

-0.77 (-2.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 03

    May

  • 09

    May

  • 22

    May

  • 23

    May

BUD

AB InBev

$108.28

-0.81 (-0.74%)

07:24
04/24/17
04/24
07:24
04/24/17
07:24
Technical Analysis
AB InBev rallies in early pre-market trading »

The shares were last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADMS

Adamas Pharmaceuticals

$15.57

-0.05 (-0.32%)

, AVXS

AveXis

$76.76

-0.24 (-0.31%)

07:23
04/24/17
04/24
07:23
04/24/17
07:23
Conference/Events
American Academy of Neurology »

69th Annual Meeting of…

ADMS

Adamas Pharmaceuticals

$15.57

-0.05 (-0.32%)

AVXS

AveXis

$76.76

-0.24 (-0.31%)

CATB

Catabasis Pharmaceuticals

$1.45

-0.07 (-4.61%)

MNOV

MediciNova

$5.83

0.08 (1.39%)

IONS

Ionis Pharmaceuticals

$44.26

1.35 (3.15%)

FLKS

Flex Pharma

$3.08

-0.5 (-13.97%)

TGTX

TG Therapeutics

$10.30

-0.15 (-1.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 25

    Apr

  • 24

    May

  • 05

    Jun

  • 05

    Jun

  • 06

    Jun

  • 24

    Aug

VAC

Marriott Vacations

$104.42

1.54 (1.50%)

, WYN

Wyndham

$89.72

-0.03 (-0.03%)

07:22
04/24/17
04/24
07:22
04/24/17
07:22
Recommendations
Marriott Vacations, Wyndham, Extended Stay America analyst commentary  »

A few hotel chanins…

VAC

Marriott Vacations

$104.42

1.54 (1.50%)

WYN

Wyndham

$89.72

-0.03 (-0.03%)

STAY

Extended Stay America

$17.24

-0.07 (-0.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 27

    Apr

  • 04

    May

CGIX

Cancer Genetics

$4.05

0.1 (2.53%)

07:21
04/24/17
04/24
07:21
04/24/17
07:21
Hot Stocks
Cancer Genetics launches Complete::IO panel »

Cancer Genetics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRV

Travelers

$119.10

0.22 (0.19%)

07:21
04/24/17
04/24
07:21
04/24/17
07:21
Upgrade
Travelers rating change  »

Travelers upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FLT

FleetCor

$147.66

-2.07 (-1.38%)

07:21
04/24/17
04/24
07:21
04/24/17
07:21
Recommendations
FleetCor analyst commentary  »

FleetCor should be bought…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

DB

Deutsche Bank

$16.50

-0.05 (-0.30%)

07:21
04/24/17
04/24
07:21
04/24/17
07:21
Technical Analysis
Deutsche Bank rallies sharply in pre-market »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RLJ

RLJ Lodging Trust

$23.60

-0.2 (-0.84%)

, FCH

Felcor Lodging

$7.32

-0.05 (-0.68%)

07:20
04/24/17
04/24
07:20
04/24/17
07:20
Conference/Events
RLJ Lodging Trust and Felcor Lodging to host joint conference call »

Joint Conference call to…

RLJ

RLJ Lodging Trust

$23.60

-0.2 (-0.84%)

FCH

Felcor Lodging

$7.32

-0.05 (-0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 24

    Apr

  • 28

    Apr

AKTX

Akari Therapeutics

$20.50

4.13 (25.23%)

07:16
04/24/17
04/24
07:16
04/24/17
07:16
Hot Stocks
Akari: Interim Phase 2 PNH data demonstrate 'positive' response with Coversin »

Akari Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

WGO

Winnebago

$26.25

0.15 (0.57%)

07:15
04/24/17
04/24
07:15
04/24/17
07:15
Initiation
Winnebago initiated  »

Winnebago initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVX

Chevron

$104.89

0.01 (0.01%)

07:14
04/24/17
04/24
07:14
04/24/17
07:14
Periodicals
Chevron to sell Bangladesh gas fields to Himalaya Energy, Reuters says »

Chevron has agreed to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 31

    May

QTS

QTS Realty Trust

$52.90

-0.14 (-0.26%)

07:12
04/24/17
04/24
07:12
04/24/17
07:12
Recommendations
QTS Realty Trust analyst commentary  »

QTS Realty Trust named…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

CARA

Cara Therapeutics

$16.53

-0.56 (-3.28%)

07:12
04/24/17
04/24
07:12
04/24/17
07:12
Hot Stocks
Cara Therapeutics announces 'positive' data from Phase 1 trial of CR845 »

Cara Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

STLD

Steel Dynamics

$35.37

0.46 (1.32%)

07:10
04/24/17
04/24
07:10
04/24/17
07:10
Upgrade
Steel Dynamics rating change  »

Steel Dynamics upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKS

AK Steel

$6.72

-0.1 (-1.47%)

07:10
04/24/17
04/24
07:10
04/24/17
07:10
Upgrade
AK Steel rating change  »

AK Steel upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 25

    May

NUE

Nucor

$60.00

-0.35 (-0.58%)

07:10
04/24/17
04/24
07:10
04/24/17
07:10
Upgrade
Nucor rating change  »

Nucor upgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

X

U.S. Steel

$30.42

-0.09 (-0.29%)

07:10
04/24/17
04/24
07:10
04/24/17
07:10
Upgrade
U.S. Steel rating change  »

U.S. Steel upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

AKZOY

AkzoNobel

$27.96

-0.11 (-0.39%)

, PPG

PPG

$105.94

-0.43 (-0.40%)

07:09
04/24/17
04/24
07:09
04/24/17
07:09
Hot Stocks
Breaking Hot Stocks news story on AkzoNobel, PPG »

AkzoNobel confirms third…

AKZOY

AkzoNobel

$27.96

-0.11 (-0.39%)

PPG

PPG

$105.94

-0.43 (-0.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAGE

SAGE Therapeutics

$72.82

1.19 (1.66%)

07:09
04/24/17
04/24
07:09
04/24/17
07:09
Hot Stocks
SAGE Therapeutics appoints Michael Cloonan as Chief Business Officer »

Sage Therapeutics (SAGE)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOMA

XOMA

$7.73

0.26 (3.48%)

07:09
04/24/17
04/24
07:09
04/24/17
07:09
Hot Stocks
XOMA says X213 shown to be safe and effective in phase 2 study »

XOMA Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    May

AMDA

Amedica

$0.38

0.01 (2.70%)

07:08
04/24/17
04/24
07:08
04/24/17
07:08
Hot Stocks
Amedica announces regulatory clearance to market, sell Valeo in Australia »

Amedica Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.